Genomic Health, Inc. (GHDX) - Product Pipeline Analysis

Genomic Health, Inc. (GHDX) - Product Pipeline Analysis

Aug 2012 GlobalData Market Guide35 Pages Price :
$ 750

Genomic Health, Inc. (Genomic Health) is a molecular diagnostics company. The company undertakes genomic research to develop molecular diagnostics which give individualized information on response to certain types of therapy. It focuses on the research, development and commercialization of genomic-based clinical laboratory services for the treatment of cancer. The company is focused on improving the quality of treatment decisions for cancer patients by offering individualized information to patients and their physicians through the genomic analysis of tumor biopsies. The companys Oncotype DX platform uses quantitative genomic analysis in standard tumor pathology specimens for providing tumor-specific information. Its key products include Oncotype DX breast cancer test and Oncotype DX colon cancer test. The company\'s pipeline products include products treating various cancers namely, breast cancer, renal cancer, prostate cancer, non-small cell lung cancer, colon cancer and melanoma. Genomic Health is headquartered in California, the US.

This report is a source for data, analysis and actionable intelligence on the Genomic Health, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 4
Genomic Health, Inc. - Business Description 5

Key Facts 6
Genomic Health, Inc. - Major Products and Services 7
Genomic Health, Inc. Pipeline Products by Equipment Type 8
Genomic Health, Inc. Pipeline Products by Development Stage 10
Genomic Health, Inc. Pipeline Products by Therapy Area 12
Genomic Health, Inc. Pipeline Products by Milestone Summary 14
Next Generation Oncotype DX - Breast Cancer Assay 16
Next Generation Oncotype DX - Breast Cancer Assay Product Status 16
Next Generation Oncotype DX - Breast Cancer Assay Product Description 16
Oncotype DX - Prostate Cancer Assay 17
Oncotype DX - Prostate Cancer Assay Product Status 17
Oncotype DX - Prostate Cancer Assay Product Description 17
Oncotype DX - Prostate Cancer Assay Product Milestone 17
Oncotype Dx Colon Cancer Assay - Oxaliplatin 19
Oncotype Dx Colon Cancer Assay - Oxaliplatin Product Status 19
Oncotype Dx Colon Cancer Assay - Oxaliplatin Product Description 19
Prognostic Test - Melanoma 20
Prognostic Test - Melanoma Product Status 20
Prognostic Test - Melanoma Product Description 20
Prognostic Test - Non Small Cell Lung Cancer 21
Prognostic Test - Non Small Cell Lung Cancer Product Status 21
Prognostic Test - Non Small Cell Lung Cancer Product Description 21
Prognostic Test - Non-Metastatic Renal Cell Carcinoma 22
Prognostic Test - Non-Metastatic Renal Cell Carcinoma Product Status 22
Prognostic Test - Non-Metastatic Renal Cell Carcinoma Product Description 22
Prognostic Test - Non-Metastatic Renal Cell Carcinoma Product Milestone 22
Product Institution Details 22
Genomic Health, Inc. - Key Competitors 23
Genomic Health, Inc. - Key Employees 24
Genomic Health, Inc. - Key Employee Biographies 25
Genomic Health, Inc. - Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Genomic Health, Inc., Recent Developments 27
Jun 01, 2012: Genomic Health Announces Results Of Eighteen Studies Covering Colon, Prostate And Breast Cancers At ASCO 2012 Annual Meeting 27
May 16, 2012: Genomic Health To Present Eighteen Studies Highlighting Progress In Breast, Colon And Prostate Cancers At ASCO 2012 Annual Meeting 28
May 02, 2012: Genomic Health Reports Revenue Of $58.5m In Q1 2012 29
Feb 06, 2012: Genomic Health Announces Formation Of New Genetics Subsidiary 30
Feb 06, 2012: Genomic Health Reports Revenue Of $206.1m In 2011 30
Feb 03, 2012: Genomic Health Presents Results Furthering Understanding Of Biology Of Prostate Cancer At 2012 Genitourinary Cancers Symposium 31
Nov 29, 2011: Genomic Health Announces Presentation Of 16 Oncotype DX Studies At 2011 CTRC-AACR San Antonio Breast Cancer Symposium 32
Nov 29, 2011: Genomic Health Announces Presentation Of 16 Oncotype DX Studies At 2011 CTRC-AACR San Antonio Breast Cancer Symposium 32
Nov 29, 2011: Genomic Health Announces Presentation Of 16 Oncotype DX Studies At 2011 CTRC-AACR San Antonio Breast Cancer Symposium 33
Nov 01, 2011: Genomic Health Reports Revenue Of $52m In Q3 2011 33

Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Table


Genomic Health, Inc., Key Facts 1
Genomic Health, Inc. Key Pipeline Products by Equipment Type 1
Genomic Health, Inc. Key Pipeline Products by Therapy Area 1
Genomic Health, Inc. Key Pipeline Products by Development Stage 1
Genomic Health, Inc., Key Facts 6
Genomic Health, Inc., Major Products and Services 7
Genomic Health, Inc. Number of Pipeline Products by Equipment Type 8
Genomic Health, Inc. Pipeline Products by Equipment Type 9
Genomic Health, Inc. Number of Pipeline Products by Development Stage 10
Genomic Health, Inc. Pipeline Products by Development Stage 11
Genomic Health, Inc. Number of Pipeline Products by Therapy Area 12
Genomic Health, Inc. Pipeline Products by Therapy Area 13
Genomic Health, Inc. Number of Pipeline Products By Milestone Summary 14
Genomic Health, Inc. Pipeline Products by Milestone Summary 15
Next Generation Oncotype DX - Breast Cancer Assay - Product Status 16
Next Generation Oncotype DX - Breast Cancer Assay - Product Description 16
Oncotype DX - Prostate Cancer Assay - Product Status 17
Oncotype DX - Prostate Cancer Assay - Product Description 17
Oncotype DX - Prostate Cancer Assay - Product Milestone 17
Oncotype Dx Colon Cancer Assay - Oxaliplatin - Product Status 19
Oncotype Dx Colon Cancer Assay - Oxaliplatin - Product Description 19
Prognostic Test - Melanoma - Product Status 20
Prognostic Test - Melanoma - Product Description 20
Prognostic Test - Non Small Cell Lung Cancer - Product Status 21
Prognostic Test - Non Small Cell Lung Cancer - Product Description 21
Prognostic Test - Non-Metastatic Renal Cell Carcinoma - Product Status 22
Prognostic Test - Non-Metastatic Renal Cell Carcinoma - Product Description 22
Prognostic Test - Non-Metastatic Renal Cell Carcinoma - Product Milestone 22
Genomic Health, Inc., Key Employees 24
Genomic Health, Inc., Key Employee Biographies 25
Genomic Health, Inc., Other Locations 26

List of Chart


Genomic Health, Inc. Key Pipeline Products by Equipment Type 1
Genomic Health, Inc. Pipeline Products by Equipment Type 8
Genomic Health, Inc. Pipeline Products by Development Stage 10
Genomic Health, Inc. Pipeline Products by Therapy Area 12
Genomic Health, Inc. Pipeline Products by Milestone Summary 14

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 750
$ 1500

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top